Abstract:BackgroundDuchenne Muscular Dystrophy (DMD) is the most common muscle disease in children, and there are no effective therapies for DMD or Becker Muscular Dystrophy (BMD). Currently, targeted gene therapy treatments have emerged. As a result, genetic diagnosis is the basis of treatment. In addition, genetic and prenatal diagnosis significantly reduces their incidence rates. This study combines the application of multiplex ligation-dependent probe amplification technology (MLPA) and "next-generation" sequencing technology (NGS) as the most economical and efficient method of diagnosis. Therefore, in the diagnosis of DMD/BMD, patients' MLPA data are first used to detect DMD gene deletions or duplications, and NGS and Sanger sequencing are then applied to exclude MLPA-negative samples. Meanwhile, polymerase chain reaction (PCR) is used to detect single exon deletions to exclude false-positives in MLPA caused by point mutations.MethodsIn this study, we recruited 1051 proband families of DMD from 2016 to 2018 and had access to information that could identify individual participants during or after data collection. Patients who were diagnosed with DMD were first tested by MLPA. MLPA results with single exon deletions were validated with PCR amplification and Sanger sequencing. The negative results of MLPA were further analysed with NGS and validated by Sanger sequencing. For novel missense mutations, phenotype-genotype correlations were analysed using PolyPhen2 and mutation taster. All methods were performed in accordance with the relevant guidelines and regulations.ResultsDMD mutations were identified in 1029 families (97.91%, 1029/1051). Large deletions, duplications, and small mutations accounted for 70.41% (740/1051), 8.28% (87/1051), and 19.12% (201/1051) of all cases, respectively. There were 205 small mutation types, 53 of which were novel. The rate of de novo mutations was 39.45% (187/474) and was higher in large duplications (49.53%, 157/317). Among 68 asymptomatic patients (< 3 years old) with unexplained persistent hyperCKaemia upon conventional physical examination, 63 were diagnosed as DMD/BMD according to genetic diagnosis.ConclusionOur results expand the spectrum of DMD mutations, which could contribute to the treatment of DMD/BMD and provide an effective diagnosis method. Thus, the combination of MLPA, NGS and Sanger sequencing is of great significance for family analysis, gene diagnosis and gene therapy.

X-Linked Markers in the Duchenne Muscular Dystrophy Gene Associated with Oral Clefts

A Genome-Wide Association Study of Cleft Lip with and Without Cleft Palate Identifies Risk Variants Near MAFB and ABCA4

Gene‐Gene Interaction among WNT Genes for Oral Cleft in Trios

Comprehensive Genetic Diagnosis of Patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) and Pathogenicity Analysis of Splice Site Variants in the DMD Gene

Association Between Genes on Chromosome 4p16 and Non-Syndromic Oral Clefts in Four Populations.

Targeted Next-Generation Sequencing As a Comprehensive Test for Patients with and Female Carriers of DMD/BMD: a Multi-Population Diagnostic Study

Genetic analysis of 1051 Chinese families with Duchenne/Becker Muscular Dystrophy

Whole Exome Sequencing of Distant Relatives in Multiplex Families Implicates Rare Variants in Candidate Genes for Oral Clefts.

Gene‐gene Interaction of Single Nucleotide Polymorphisms in 16p13.3 May Contribute to the Risk of Non‐syndromic Cleft Lip with or Without Cleft Palate in Chinese Case‐parent Trios

Screening of Duchenne Muscular Dystrophy (DMD) Mutations and Investigating Its Mutational Mechanism in Chinese Patients.

A Genome-Wide Association Study Of Cleft Lip With And Without Cleft Palate Identifies Risk Variants Near Mafb And Abca4 (Vol 42, Pg 525, 2010)

Gene-gene Interaction Between MSX1 and TP63 in Asian Case-Parent Trios with Nonsyndromic Cleft Lip with or Without Cleft Palate

Examining markers in 8q24 to explain differences in evidence for association with cleft lip with/without cleft palate between Asians and Europeans.

Characteristics of Dystrophin Gene Mutations among Chinese Patients As Revealed by Multiplex Ligation–Dependent Probe Amplification

Joint Testing of Genotypic and Gene-Environment Interaction Identified Novel Association for BMP4 with Non-Syndromic CL/P in an Asian Population Using Data from an International Cleft Consortium

Genome-wide association study identifies a new susceptibility locus for cleft lip with or without a cleft palate.

A Multi-Ethnic Genome-Wide Association Study Identifies Novel Loci for Non-Syndromic Cleft Lip with or Without Cleft Palate on 2p24.2, 17q23 and 19Q13

Pathway Analysis Identified a Significant Association Between Cell-Cell Adherens Junctions-Related Genes and Non-Syndromic Cleft Lip/palate in 895 Asian Case-Parent Trios.

Multi-ancestry Genome Wide Association Study Meta-analysis of Non-syndromic Orofacial Clefts

[Exploring the Association Between De Novo Mutations and Non-Syndromic Cleft Lip with or Without Palate Based on Whole Exome Sequencing of Case-Parent Trios].

Analysis of Sequence Data to Identify Potential Risk Variants for Oral Clefts in Multiplex Families.